Filing Flows › Silence Therapeutics (SLN) › Who owns the stock
Who owns Silence Therapeutics (SLN) stock
70 funds reported Silence Therapeutics (SLN) shares in their latest 13F filings, worth $262M in all. The largest holder is Siren, L.L.C. ($36.4M). Last quarter 40 funds added to their stakes and 21 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Siren, L.L.C. | 3,311,438 | $36.4M | increase | 2026-06-30 |
| TCG Crossover Management, LLC | 3,033,560 | $33.3M | unchanged | 2026-06-30 |
| Nantahala Capital Management, LLC | 2,693,462 | $29.6M | increase | 2026-06-30 |
| Redmile Group, LLC | 2,164,777 | $23.8M | unchanged | 2026-06-30 |
| Citadel Advisors LLC | 1,329,625 | $14.6M | increase | 2026-06-30 |
| Nextech Invest | 952,400 | $10.5M | unchanged | 2026-06-30 |
| Millennium Management LLC | 909,279 | $10.0M | decrease | 2026-06-30 |
| TFG Asset Management GP | 764,256 | $8.4M | increase | 2026-06-30 |
| Soleus Capital Management, L.P. | 630,000 | $6.9M | new | 2026-06-30 |
| Balyasny Asset Management L.P. | 610,980 | $6.7M | new | 2026-06-30 |
| Nextech Invest | 952,400 | $6.6M | unchanged | 2024-12-31 |
| 5AM Venture Management, LLC | 476,200 | $5.2M | unchanged | 2026-06-30 |
| Great Point Partners LLC | 450,000 | $4.9M | decrease | 2026-06-30 |
| Morgan Stanley | 403,172 | $4.4M | increase | 2026-06-30 |
| Ameriprise Financial | 370,052 | $4.1M | new | 2026-06-30 |
Silence Therapeutics' latest quarter
Silence Therapeutics, Q1 2026: revenue $422K (+197% year over year), net loss $15.0M, operating cash flow −$15.6M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most SLN stock?
By the latest 13F filings: Siren, L.L.C. ($36.4M); TCG Crossover Management, LLC ($33.3M); Nantahala Capital Management, LLC ($29.6M); Redmile Group, LLC ($23.8M); Citadel Advisors LLC ($14.6M).
What is the short interest in SLN?
2,927,366 shares were sold short at the 2026-10-15 settlement, 15.33% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.